Literature DB >> 17366051

A community outbreak of Legionnaires' disease from an industrial cooling tower: assessment of clinical features and diagnostic procedures.

Anna Hugosson1, Martin Hjorth, Sverker Bernander, Berndt E B Claesson, Agneta Johansson, Helena Larsson, Peter Nolskog, Judit Pap, Nils Svensson, Peter Ulleryd.   

Abstract

An outbreak of Legionnaires' disease (LD) occurred in Lidköping, Sweden, in August 2004. A cooling tower was identified as the probable source of infection. During the outbreak period an unexpected 3-6-fold increase in pneumonia patients was noted at the local hospital. During 7 weeks LD was diagnosed in 15 patients by urinary antigen and/or sputum culture. Additionally, 15 LD patients were diagnosed later by serology. Patients with LD were generally younger, more healthy, and more often smokers compared to other pneumonia patients. On admittance they had more severe symptoms with high fever and raised CRP levels, and more often hyponatraemia, gastrointestinal and CNS symptoms. A causative agent besides Legionella was found in 2 patients only. A significant titre rise for Mycoplasma and/or Chlamydophila pneumoniae was found in 13 of 29 tested patients with confirmed LD. We conclude that the clinical diagnosis of LD is difficult and that available diagnostic methods detect only a minority of patients in the acute phase. Therefore in severe pneumonia, empirically targeted therapy should be instituted on clinical grounds irrespective of the results of diagnostic tests. The observation of increased antibody levels for M. and C. pneumoniae suggests an unspecific immune reaction and merits further study.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17366051     DOI: 10.1080/00365540601001930

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  A Large Community Outbreak of Legionnaires' Disease Associated With a Cooling Tower in New York City, 2015.

Authors:  Don Weiss; Christopher Boyd; Jennifer L Rakeman; Sharon K Greene; Robert Fitzhenry; Trevor McProud; Kimberlee Musser; Li Huang; John Kornblum; Elizabeth J Nazarian; Annie D Fine; Sarah L Braunstein; Daniel Kass; Keren Landman; Pascal Lapierre; Scott Hughes; Anthony Tran; Jill Taylor; Deborah Baker; Lucretia Jones; Laura Kornstein; Boning Liu; Rodolfo Perez; David E Lucero; Eric Peterson; Isaac Benowitz; Kristen F Lee; Stephanie Ngai; Mitch Stripling; Jay K Varma
Journal:  Public Health Rep       Date:  2017-01-31       Impact factor: 2.792

2.  In Situ Biomineralization and Particle Deposition Distinctively Mediate Biofilm Susceptibility to Chlorine.

Authors:  Xiaobao Li; David L Chopp; William A Russin; Paul T Brannon; Matthew R Parsek; Aaron I Packman
Journal:  Appl Environ Microbiol       Date:  2016-05-02       Impact factor: 4.792

3.  Characterization of the extent of a large outbreak of Legionnaires' disease by serological assays.

Authors:  Øystein Simonsen; Elisabeth Wedege; Anita Kanestrøm; Karin Bolstad; Ingeborg S Aaberge; Eivind Ragnhildstveit; Jetmund Ringstad
Journal:  BMC Infect Dis       Date:  2015-03-28       Impact factor: 3.090

4.  Free-living amoebae and their associated bacteria in Austrian cooling towers: a 1-year routine screening.

Authors:  Ute Scheikl; Han-Fei Tsao; Matthias Horn; Alexander Indra; Julia Walochnik
Journal:  Parasitol Res       Date:  2016-05-14       Impact factor: 2.289

Review 5.  Outbreaks of Legionnaires' Disease and Pontiac Fever 2006-2017.

Authors:  K A Hamilton; A J Prussin; W Ahmed; C N Haas
Journal:  Curr Environ Health Rep       Date:  2018-06

6.  Legionnaires' disease from a cooling tower in a community outbreak in Lidköping, Sweden- epidemiological, environmental and microbiological investigation supported by meteorological modelling.

Authors:  Peter Ulleryd; Anna Hugosson; Görel Allestam; Sverker Bernander; Berndt E B Claesson; Ingrid Eilertz; Anne-Christine Hagaeus; Martin Hjorth; Agneta Johansson; Birgitta de Jong; Anna Lindqvist; Peter Nolskog; Nils Svensson
Journal:  BMC Infect Dis       Date:  2012-11-21       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.